Click Therapeutics CEO and leadership

David Benshoof Klein is a healthcare investor and entrepreneur with over 19 years life science industry experience; he has played key roles in founding, financing and operating more than 10 life science companies. In 2012, Mr. Klein co-founded Click Therapeutics which develops and commercializes software as medical treatments: Digital Therapeutics™. Following a groundbreaking clinical trial, Click’s industry-leading smoking cessation program is available nationwide through a wide variety of payers, providers, and employers. Click is also progressing a broad pipeline of prescription Digital Therapeutics across a variety of high-burden therapeutic areas, including Major Depressive Disorder, Schizophrenia, Acute Coronary Syndrome, Migraine, Chronic Pain, Insomnia, COPD, Obesity, and more. He formerly served as Managing Director at Opus Point Partners, senior consultant to Pfizer, and strategic advisor to numerous publicly traded and privately held life science companies. Mr. Klein has been a guest lecturer at Columbia University’s Biotechnology Program, Columbia Business School, and NYU Stern School of Business. Mr. Klein holds a B.A. from Brandeis University, and was recognized by Goldman Sachs in 2019 as one of the 100 most intriguing entrepreneurs at its annual Builders & Innovators conference. A native New Yorker, Mr. Klein is an avid art enthusiast and is co-founder and owner of Eli Klein Gallery, America’s leading Chinese contemporary art gallery with locations in New York’s Chelsea art district and Beijing, China.

Randall Stanicky is a Chief Financial Officer at Click Therapeutics Inc and Board Member at Children's Tumor Foundation and is based in New, York. He has worked as Mng Dir:Global Equity Research at RBC Capital Markets; Board Member at THERAPEUTICSMD, INC.; and Managing Director/Analyst at Canaccord Genuity Group Inc. Randall attended University of British Columbia.

Entrepreneur + IT Investment + Product Design + Sales/Marketing + Strategist + Business Development. My passion is to develop innovative, usable and useful digital healthcare products.

Healthcare leaders are just now taking advantage of patient engagement technology solutions that standardize healthcare programs to improve outcomes, drive revenue, and reduce costs. Click Therapeutics technology allows for interactive coaching, evidence based treatment protocols delivered interactively, real time tracking of symptoms, facilitating rapid communication between patient and provider, entertaining and educational experience (edutainment), goal tracking and more.

►If you’re interested in a quick conversation on how we can implement an interactive patient or member engagement program for you, call me at 347-407-0803 or email wei@clicktherapeutics.com

Working to advance the the design, validation and commercialization of novel digital therapeutics that have demonstrated safety and efficacy, with the goal of establishing DTx as a trusted new category of treatment options. Professional interests include personalized medicine, digital biomarkers, machine learning, advanced study designs, preventative and integrated care, platform product strategies, user experience/product design, and translating early research and product planning into prescription-ready products for patients.

CTO at Click, where I am building a platform of software products which provide self-personalizing prescription medical treatment to a variety of disease indications.

David Benshoof Klein is a healthcare investor and entrepreneur with over 19 years life science industry experience; he has played key roles in founding, financing and operating more than 10 life science companies. In 2012, Mr. Klein co-founded Click Therapeutics which develops and commercializes software as medical treatments: Digital Therapeutics™. Following a groundbreaking clinical trial, Click’s industry-leading smoking cessation program is available nationwide through a wide variety of payers, providers, and employers. Click is also progressing a broad pipeline of prescription Digital Therapeutics across a variety of high-burden therapeutic areas, including Major Depressive Disorder, Schizophrenia, Acute Coronary Syndrome, Migraine, Chronic Pain, Insomnia, COPD, Obesity, and more. He formerly served as Managing Director at Opus Point Partners, senior consultant to Pfizer, and strategic advisor to numerous publicly traded and privately held life science companies. Mr. Klein has been a guest lecturer at Columbia University’s Biotechnology Program, Columbia Business School, and NYU Stern School of Business. Mr. Klein holds a B.A. from Brandeis University, and was recognized by Goldman Sachs in 2019 as one of the 100 most intriguing entrepreneurs at its annual Builders & Innovators conference. A native New Yorker, Mr. Klein is an avid art enthusiast and is co-founder and owner of Eli Klein Gallery, America’s leading Chinese contemporary art gallery with locations in New York’s Chelsea art district and Beijing, China.

Randall Stanicky is a Chief Financial Officer at Click Therapeutics Inc and Board Member at Children's Tumor Foundation and is based in New, York. He has worked as Mng Dir:Global Equity Research at RBC Capital Markets; Board Member at THERAPEUTICSMD, INC.; and Managing Director/Analyst at Canaccord Genuity Group Inc. Randall attended University of British Columbia.

Entrepreneur + IT Investment + Product Design + Sales/Marketing + Strategist + Business Development. My passion is to develop innovative, usable and useful digital healthcare products.

Healthcare leaders are just now taking advantage of patient engagement technology solutions that standardize healthcare programs to improve outcomes, drive revenue, and reduce costs. Click Therapeutics technology allows for interactive coaching, evidence based treatment protocols delivered interactively, real time tracking of symptoms, facilitating rapid communication between patient and provider, entertaining and educational experience (edutainment), goal tracking and more.

►If you’re interested in a quick conversation on how we can implement an interactive patient or member engagement program for you, call me at 347-407-0803 or email wei@clicktherapeutics.com